The Gurugram Raid: How Counterfeit Mounjaro Was Exposed

The investigation began when authorities noticed conspicuous discrepancies in the packaging of Mounjaro injections being distributed in Gurugram’s DLF Phase 4 area. According to officials from the Drugs Control Office, the counterfeit products exhibited several red flags:

  • Color mismatches: The boxes of the fake injections featured different shades of blue and red compared to the authentic product.
  • Typographical errors: Glaring spelling and grammatical mistakes were found on the packaging of the counterfeit versions.
  • Blurred imagery: The illustration of the injection pen on the fake boxes was dark, blurred, and shorter than the clear, bright image on the original packaging.

During the raid on April 18, 2026, authorities seized the counterfeit injections from a vehicle and later traced the operation to a flat in Gurugram’s Sector 62, where the drugs were allegedly prepared. The alleged mastermind, Avi Sharma, was arrested alongside a deliveryman, Mujjamil. Sharma reportedly sourced raw materials from China through the e-commerce platform Alibaba and mixed them with water to produce the counterfeit injections.

Beyond Mounjaro: The Broader Counterfeit Drug Operation

The investigation took a darker turn when authorities discovered that Sharma was not only producing counterfeit Mounjaro but likewise selling unapproved tirzepatide-based injections under his own brand, “ToneUp.” According to reports from CNBCTV18, Sharma had produced 15-16 vials of “ToneUp,” which were marketed as weight-loss injections and sold online for prices ranging between ₹11,000 and ₹18,000 ($130-$215).

Gurugram Drug Control Officer Amandeep Chauhan warned that “ToneUp” had no regulatory approval and had never undergone safety testing. “Anyone who has these injections should not employ them at all,” Chauhan emphasized. Authorities have since traced some of the vials to buyers in Delhi, Hyderabad, and other cities, initiating a nationwide recall to prevent further harm.

The Dangers of Counterfeit Medications

Counterfeit drugs pose a severe risk to public health, particularly when they involve life-saving or chronic disease medications like Mounjaro. Unlike legitimate pharmaceuticals, counterfeit versions often lack the active ingredients necessary to treat the condition they claim to address. In some cases, they may contain harmful substances, incorrect dosages, or contaminants that can lead to adverse reactions, treatment failure, or even death.

For patients relying on Mounjaro to manage type 2 diabetes or obesity, counterfeit versions can have devastating consequences. Tirzepatide, the active ingredient in Mounjaro, works by mimicking hormones that regulate blood sugar and appetite. Without the correct formulation, patients may experience uncontrolled blood sugar levels, worsening of their condition, or unexpected side effects from unknown substances in the counterfeit product.

Why Mounjaro Is a Prime Target for Counterfeiters

Mounjaro has become one of the most sought-after drugs in recent years due to its effectiveness in treating type 2 diabetes and promoting weight loss. Its popularity has driven demand to unprecedented levels, creating a lucrative opportunity for counterfeiters. The high cost of the medication—often exceeding ₹20,000 ($240) per month for legitimate prescriptions—further incentivizes the production of cheaper, fake alternatives.

According to India Today, the surge in demand for GLP-1 therapies like Mounjaro has made them a prime target for counterfeiters. The global market for these drugs is projected to reach $100 billion by 2030, making it an attractive sector for illicit operations.

How to Identify Counterfeit Medications

With counterfeit drugs becoming increasingly sophisticated, patients and healthcare providers must remain vigilant. Here are key warning signs to look for when identifying fake medications:

Packaging Red Flags

  • Color and design discrepancies: Compare the packaging to images of the authentic product. Look for differences in color shades, logos, or branding.
  • Typographical errors: Spelling mistakes, grammatical errors, or awkward phrasing on the packaging or labels are common in counterfeit products.
  • Blurred or low-quality imagery: Counterfeiters often use low-resolution images or poorly printed labels.

Product Quality

  • Inconsistent labeling: Check for missing or incorrect batch numbers, expiration dates, or manufacturer information.
  • Unusual texture or appearance: If the medication looks different from what you’ve used before (e.g., different color, shape, or consistency), it may be counterfeit.
  • Packaging defects: Poorly sealed containers, missing safety seals, or tamper-evident features that appear broken are major red flags.

Purchasing Safeguards

  • Buy from licensed pharmacies: Always purchase medications from reputable, licensed pharmacies or authorized online retailers.
  • Avoid “too good to be true” deals: If a medication is being sold at a significantly lower price than usual, it may be counterfeit.
  • Verify the source: Check the manufacturer’s website for a list of authorized sellers. For Mounjaro, Eli Lilly provides resources to verify authenticity.
  • Consult your healthcare provider: If you suspect you’ve received a counterfeit medication, contact your doctor or pharmacist immediately.

The Global Fight Against Counterfeit Drugs

The Gurugram case is not an isolated incident. Counterfeit medications are a global problem, with the World Health Organization (WHO) estimating that 1 in 10 medical products in low- and middle-income countries is substandard or falsified. In high-income countries, the problem is also growing, fueled by the rise of online pharmacies and unregulated marketplaces.

Product Quality
Check Avoid

In the United States, the Food and Drug Administration (FDA) has ramped up efforts to combat counterfeit drugs, including increased inspections of international mail facilities and collaboration with global partners to track illicit supply chains. Similarly, the European Medicines Agency (EMA) has implemented stricter regulations to prevent counterfeit medications from entering the EU market.

However, the fight against counterfeit drugs requires a multi-pronged approach involving governments, pharmaceutical companies, healthcare providers, and patients. Key strategies include:

  • Enhanced regulatory oversight: Strengthening laws and penalties for counterfeit drug production and distribution.
  • Public awareness campaigns: Educating patients and healthcare providers on how to identify and report counterfeit medications.
  • Advanced authentication technologies: Implementing tamper-evident packaging, QR codes, and blockchain-based tracking systems to verify the authenticity of medications.
  • International collaboration: Sharing intelligence and coordinating efforts across borders to dismantle counterfeit drug networks.

Eli Lilly’s Response: Protecting Patients from Counterfeit Mounjaro

In response to the Gurugram raid, Eli Lilly, the manufacturer of Mounjaro, issued a statement reaffirming its commitment to patient safety. The company emphasized that it works closely with global regulatory agencies and law enforcement to combat counterfeit medications and protect patients from harm.

“Counterfeit medicines pose a serious threat to patient safety and undermine the trust in legitimate healthcare products. We urge patients to only obtain Mounjaro from authorized sources and to report any suspicious products to the appropriate authorities.”

— Eli Lilly Statement on Counterfeit Mounjaro

Eli Lilly has also implemented several measures to help patients verify the authenticity of Mounjaro, including:

  • A dedicated authentication portal where patients can check the legitimacy of their medication.
  • Educational resources on how to identify counterfeit Mounjaro, including packaging guides and warning signs.
  • Collaboration with online marketplaces to remove listings of counterfeit or unauthorized Mounjaro products.

Key Takeaways: What You Need to Grasp

  • Counterfeit Mounjaro injections worth ₹70 lakh were seized in Gurugram after authorities noticed discrepancies in packaging, including color mismatches and typographical errors.
  • The counterfeit drugs were produced by mixing raw materials sourced from China with water and were distributed through unregulated channels.
  • The alleged mastermind, Avi Sharma, also sold unapproved tirzepatide-based injections under the brand “ToneUp,” which had no regulatory approval and posed significant health risks.
  • Counterfeit medications can be deadly, as they may lack active ingredients, contain harmful substances, or deliver incorrect dosages.
  • Patients should purchase medications only from licensed pharmacies and verify the authenticity of their drugs using manufacturer resources.
  • Global efforts to combat counterfeit drugs include enhanced regulations, public awareness campaigns, and advanced authentication technologies.

What’s Next? The Future of Drug Safety

The Gurugram raid serves as a stark reminder of the ongoing battle against counterfeit medications. As demand for drugs like Mounjaro continues to rise, so too will the efforts of counterfeiters to exploit vulnerable patients. However, advancements in technology, such as AI-driven supply chain monitoring and blockchain-based authentication, offer promising solutions to enhance drug safety.

Spotting fake medicines with your mobile phone – BBC What's New

For now, the responsibility lies with patients, healthcare providers, and regulators to remain vigilant. By staying informed and taking proactive steps to verify the authenticity of medications, we can help protect ourselves and our communities from the dangers of counterfeit drugs.

If you suspect you’ve encountered a counterfeit medication, report it immediately to your local health authorities or the WHO’s Global Surveillance and Monitoring System.